Search research articles
Contact Us
Filters
Showing results (151-160 of 264) with videos related to
Page
of 27
Sort By:
Haematologica
|
September 18, 2012
Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie
Marlene Troch, Barbara Kiesewetter, Wolfgang Willenbacher, et al.
The Oncologist
|
January 11, 2024
Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study
Marianne Pavel, Harald Lahner, Dieter Hörsch, et al.
Plos One
|
August 1, 2014
Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients
Barbara Kiesewetter, Julius Lukas, Andreas Kuchar, et al.
Pharmacological Research
|
October 13, 2025
K<sub>V</sub>11.1 (hERG1)-centered macromolecular membrane complexes regulate proliferation in B cell lymphomas and constitute novel pharmacological targets
Cesare Sala, Jessica Iorio, Claudia Duranti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer
Werner Scheithauer, Gabriela V Kornek, Markus Raderer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2002
Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor
Gabriela V Kornek, Karin Haider, Werner Kwasny, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2003
111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study
Shuren Li, Amir Kurtaran, Mei Li, et al.
Oncology
|
January 16, 2007
Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma
Markus Raderer, Stefan Wohrer, Berthold Streubel, et al.
Wiener Klinische Wochenschrift
|
August 19, 2021
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center
Julia M Berger, Margaretha Gansterer, Wolfgang Trutschnig, et al.
Clinical & Experimental Metastasis
|
May 23, 2023
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer
Ladislaia Wolff, Ariane Steindl, Petar Popov, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 264) with videos related to
Sort By:
Page
of 27
Haematologica
|
September 18, 2012
Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie
Marlene Troch, Barbara Kiesewetter, Wolfgang Willenbacher, et al.
The Oncologist
|
January 11, 2024
Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study
Marianne Pavel, Harald Lahner, Dieter Hörsch, et al.
Plos One
|
August 1, 2014
Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients
Barbara Kiesewetter, Julius Lukas, Andreas Kuchar, et al.
Pharmacological Research
|
October 13, 2025
K<sub>V</sub>11.1 (hERG1)-centered macromolecular membrane complexes regulate proliferation in B cell lymphomas and constitute novel pharmacological targets
Cesare Sala, Jessica Iorio, Claudia Duranti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer
Werner Scheithauer, Gabriela V Kornek, Markus Raderer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2002
Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor
Gabriela V Kornek, Karin Haider, Werner Kwasny, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2003
111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study
Shuren Li, Amir Kurtaran, Mei Li, et al.
Oncology
|
January 16, 2007
Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma
Markus Raderer, Stefan Wohrer, Berthold Streubel, et al.
Wiener Klinische Wochenschrift
|
August 19, 2021
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center
Julia M Berger, Margaretha Gansterer, Wolfgang Trutschnig, et al.
Clinical & Experimental Metastasis
|
May 23, 2023
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer
Ladislaia Wolff, Ariane Steindl, Petar Popov, et al.
Page
of 27